Proteomic analysis of host responses in HepG2 cells during dengue virus infection

Journal of Proteome Research

Volumn 6, Issue 12, 2007, Pages 4592-4600

  Pattanakitsakul, Sa Nga ^a,b   Rungrojcharoenkit, Kamonthip ^a   Kanlaya, Rattiyaporn ^a   Sinchaikul, Supachok ^c   Noisakran, Sansanee ^b   Chen, Shui Tein ^c,d   Malasit, Prida ^a,b   Thongboonkerd, Visith ^a,b,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dengue; Host responses; Liver; Proteome; Proteomics; Virus

Indexed keywords

PROTEIN DEN 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL DEATH; CELL STRAIN HEPG2; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS;

CELL LINE, TUMOR; DENGUE; DENGUE VIRUS; HEPATOCYTES; HUMANS; PROTEOMICS;

DENGUE VIRUS;

EID: 38049044738     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070366b     Document Type: Article

References (40)

1. Chambers, T. J.; Hahn, C. S.; Galler, R.; Rice, C. M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44, 649-688.
2. Halstead, S. B.; Suaya, J. A.; Shepard, D. S. The burden of dengue infection. Lancet 2007, 369, 1410-1411.
3. Lei, H. Y.; Yeh, T. M.; Liu, H. S.; Lin, Y. S.; Chen, S. H.; Liu, C. C. Immunopathogenesis of dengue virus infection. J. Biomed. Sci 2001, 8, 377-388.
4. Hayes, E. B.; Gubler, D. J. Dengue and dengue hemorrhagic fever. Pediatr. Infect. Dis. J. 1992, 11, 311-317.
5. Thein, S.; Aung, M. M.; Shwe, T. N.; Aye, M.; Zaw, A.; Aye, K.; Aye, K. M.; Aaskov, J. Risk factors in dengue shock syndrome. Am. J Trop. Med. Hyg. 1997, 56, 566-572.
6. Halstead, S. B. Pathogenesis of dengue: challenges to molecular biology. Science 1988, 239, 476-481.
7. Monath, T. P. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 2395-2400.
8. Halstead, S. B. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 1989, 11 (Suppl. 4), S830-S839.
9. Kurane, I.; Rothman, A. L.; Livingston, P. G.; Green, S.; Gagnon, S. J.; Janus, J.; Innis, B. L.; Nimmannitya, S.; Nisalak, A.; Ennis, F. A. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 1994, 9, 59-64.
10. Burke, T. Dengue haemorrhagic fever: a pathological study. Trans. R. Soc. Trop. Med. Hyg. 1968, 62, 682-692.
11. Rosen, L.; Khin, M. M. U T Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res. Virol. 1989, 140, 351-360.
12. Mohan, B.; Patwari, A. K.; Anand, V. K. Hepatic dysfunction in childhood dengue infection. J. Trop. Pediatr. 2000, 46, 40-43.
13. An, J.; Kimura-Kuroda, J.; Hirabayashi, Y.; Yasui, K. Development of a novel mouse model for dengue virus infection. Virology 1999, 263, 70-77.
14. Wahid, S. F.; Sanusi, S.; Zawawi, M. M.; Ali, R. A. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J. Trop. Med. Public Health 2000, 31, 259-263.
15. Lin, Y. L.; Liu, C. C.; Lei, H. Y.; Yeh, T. M.; Lin, Y. S.; Chen, R. M.; Liu, H. S. Infection of five human liver cell lines by dengue-2 virus. J. Med. Virol. 2000, 60, 425-431.
16. Nguyen, T. L.; Nguyen, T. H.; Tieu, N. T. The impact of dengue haemorrhagic fever on liver function. Res. Virol. 1997, 148, 273-277.
17. Avirutnan, P.; Malasit, P.; Seliger, B.; Bhakdi, S.; Husmann, M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 1998, 161, 6338-6346.
18. Thongboonkerd, V.; Chutipongtanate, S.; Kanlaya, R.; Songtawee, N.; Sinchaikul, S.; Parichatikanond, P.; Chen, S. T.; Malasit, P. Proteomic identification of alterations in metabolic enzymes and signaling proteins in hypokalemic nephropathy. Proteomics 2006, 6, 2273-2285.
19. Thongboonkerd, V.; Kanlaya, R.; Sinchaikul, S.; Parichatikanond, P.; Chen, S. T.; Malasit, P. Proteomic identification of altered proteins in skeletal muscle during chronic potassium depletion: Implications for hypokalemic myopathy. J. Proteome. Res. 2006, 5, 3326-3335.
20. Marianneau, P.; Steffan, A. M.; Royer, C.; Drouet, M. T.; Kirn, A.; Deubel, V. Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line. J. Infect. Dis. 1998, 178, 1270-1278.
21. Liew, K. J.; Chow, V. T. Differential display RT-PCR analysis of ECV304 endothelial-like cells infected with dengue virus type 2 reveals messenger RNA expression profiles of multiple human genes involved in known and novel roles. J. Med. Virol. 2004, 72, 597-609.
22. Warke, R. V.; Xhaja, K.; Martin, K. J.; Fournier, M. F.; Shaw, S. K.; Brizuela, N.; de Bosch, N.; Lapointe, D.; Ennis, F. A.; Rothman, A. L.; Bosch, I. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J. Virol. 2003, 77, 11822-11832.
23. Ekkapongpisit, M.; Wannatung, T.; Susantad, T.; Triwitayakorn, K.; Smith, D. R. cDNA-AFLP analysis of differential gene expression in human hepatoma cells (HepG2) upon dengue virus infection. J. Med. Virol. 2007, 79, 552-561.
24. Klein, J. B.; Thongboonkerd, V. Overview of proteomics. Contrib. Nephrol. 2004, 141, 1-10.
25. Bushell, M.; Sarnow, P. Hijacking the translation apparatus by RNA viruses. J. Cell Biol. 2002, 158, 395-399.
26. Kushner, D. B.; Lindenbach, B. D.; Grdzelishvili, V. Z.; Noueiry, A. O.; Paul, S. M.; Ahlquisr, P. Systematic, genome-wide identification of host genes affecting replication of a positive-strand RNA virus. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 15764-15769.
27. Blumenthal, T.; Carmichael, G. G. RNA replication: function and structure of Qbeta-replicase. Annu. Rev. Biochem. 1979, 48, 525-548.
28. Jiang, X. S.; Tang, L. Y.; Dai, J.; Zhou, H.; Li, S. J.; Xia, Q. C.; Wu, J. R.; Zeng, R. Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: implications for cellular responses to virus infection. Mol. Cell. Proteomics 2005, 4, 902-913.
29. Bradsher, J. N.; Tan, S.; McLaury, H. J.; Conaway, J. W.; Conaway, R. C. RNA polymerase II transcription factor SIII. II. Functional properties and role in RNA chain elongation. J. Biol. Chem. 1993, 268, 25594-25603.
30. Garrett, K. P.; Aso, T.; Bradsher, J. N.; Foundling, S. I.; Lane, W. S.; Conaway, R. C.; Conaway, J. W. Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7172-7176.
31. Aso, T.; Lane, W. S.; Conaway, J. W.; Conaway, R. C. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 1995, 269, 1439-1443.
32. Duan, D. R.; Pause, A.; Burgess, W. H.; Aso, T.; Chen, D. Y.; Garrett, K. P.; Conaway, R. C.; Conaway, J. W.; Linehan, W. M.; Klausner, R. D. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995, 269, 1402-1406.
33. Kibel, A.; Iliopoulos, O.; DeCaprio, J. A.; Kaelin, W. G., Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 1995, 269, 1444-1446.
34. Kojima, T.; Zama, T.; Wada, K.; Onogi, H.; Hagiwara, M. Cloning of human PRP4 reveals interaction with Clk1. J. Biol. Chem. 2001, 276, 32247-32256.
35. Gross, T.; Lutzelberger, M.; Weigmann, H.; Klingenhoff, A.; Shenoy, S.; Kaufer, N. F. Functional analysis of the fission yeast Prp4 protein kinase involved in pre-mRNA splicing and isolation of a putative mammalian homologue. Nucleic Acids Res. 1997, 25, 1028-1035.
36. Wang, J.; Manley, J. L. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1995, 1, 335-346.
37. Xiao, S. H.; Manley, J. L. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 1997, 11, 334-344.
38. Ziegler, W. H.; Liddington, R. C.; Critchley, D. R. The structure and regulation of vinculin. Trends Cell Biol. 2006, 16, 453-460.
39. Subauste, M. C.; Pertz, O.; Adamson, E. D.; Turner, C. E.; Junger, S.; Hahn, K. M. Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 2004, 165, 371-381.
40. Go, E. P.; Wikoff, W. R.; Shen, Z.; O'Maille, G.; Morita, H.; Conrads, T. P.; Nordstrom, A.; Trauger, S. A.; Uritboonthai, W.; Lucas, D. A.; Chan, K. C.; Veenstra, T. D.; Lewicki, H.; Oldstone, M. B.; Schneemann, A.; Siuzdak, G. Mass spectrometry reveals specific and global molecular transformations during viral infection. J. Proteome. Res. 2006, 5, 2405-2416.